| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $653.6M | +108.0% |
| Cost of Revenue | $382.7M | +105.7% |
| Gross Profit | $270.9M | +111.3% |
| R&D Expense | $400K | -60.0% |
| SG&A Expense | $75.9M | +32.0% |
| Operating Income | -$157.8M | -3758.7% |
| Pre-tax Income | -$152.7M | -3661.6% |
| Income Tax | $34.6M | +533.0% |
| Net Income | -$187.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $614.2M | +3678.3% |
| Accounts Receivable | $63.3M | +63.4% |
| Inventory | $173.3M | -9.4% |
| Current Assets | $918.0M | +249.9% |
| Total Assets | $1.22B | +289.2% |
| Current Liabilities | $161.3M | +73.2% |
| Total Liabilities | $357.5M | +268.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $108.2M | +212.0% |
| Capital Expenditures | $8.3M | +162.3% |
| Investing Cash Flow | -$5.7M | -348.5% |
| Financing Cash Flow | $534.1M | +648.1% |
| Free Cash Flow | $99.9M | +200.2% |
| -4856.6% |
| EPS (Basic) | -$2.63 | -5360.0% |
| EPS (Diluted) | -$2.63 | -5360.0% |
| Stockholders' Equity |
| $40.1M |
| -81.5% |